Incidence and survival of vulvar and vaginal cancers in a province of Northern Italy: a population-based study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Vulvar and vaginal cancer incidence is decreasing, possibly due to HPV vaccination, but mortality remains stable, necessitating improved treatments. Long-term surveillance is crucial due to the risk of second primary malignancies.
Area Of Science
- Oncology
- Epidemiology
- Gynecologic Oncology
Background
- Vulvar and vaginal cancers are rare gynecologic malignancies.
- Understanding their incidence, mortality, and survival trends is crucial for public health.
- Focus on second primary malignancies adds complexity to patient management.
Purpose Of The Study
- To describe incidence, mortality, and survival trends of vulvar and vaginal cancers.
- To investigate the development of second primary malignancies in this cohort.
- To analyze trends over a 26-year period (1996-2021) in Northern Italy.
Main Methods
- Population-based cohort study using data from the Cancer Registry of Reggio Emilia (1996-2021).
- Analysis of incidence and mortality rates using age-standardized European Standard Population.
- Survival estimates calculated using the Pohar Perme method; trend analysis via Joinpoint Regression.
Main Results
- 328 cases identified (264 vulvar, 64 vaginal); median age at diagnosis 76.1 (vulvar) and 70.2 (vaginal).
- Vulvar cancer incidence significantly decreased (-2.3% annually); mortality stable. Vaginal cancer incidence showed a non-significant decreasing trend.
- Five-year survival: 63% (vulvar), 44% (vaginal), with significant improvement for vaginal cancer in recent years. 30 patients developed second primary malignancies.
Conclusions
- Vulvar and vaginal cancers, though rare, significantly impact older women.
- Declining incidence may reflect HPV vaccination and screening; stable mortality highlights treatment needs.
- Association with second malignancies necessitates long-term surveillance for improved outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Selection Bias: This occurs when the study population is not...
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...